journal article·2025-04Open access

Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLD

Feng Zhang, Kairui Yue, Simin Sun, Shengyuan Lu, Geng Jia, Yang Zha, Shuang Zhang, C. James Chou, Chenzhong Liao, Xiaoyang Li, Yajun Duan

Advanced Science· Volume 12· Issue 15

Abstract

Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) represents the most prevalent chronic liver disorder globally. Due to its intricate pathogenesis and the current lack of efficacious pharmacological interventions, there is a pressing need to discover novel therapeutic targets and agents for MASLD treatment. Herein, it is found that histone deacetylase 11 (HDAC11), a subtype of HDAC family, is markedly overexpressed in both in vitro and in vivo models of MASLD. Furthermore, the knockdown of HDAC11 is observed to mitigate lipid accumulation in hepatic cells. A highly selective HDAC11 inhibitor, B6, which exhibits favorable pharmacokinetic property and liver distribution, is further designed and synthesized. Integrating RNA‐seq data with in vivo and in vitro experiments, B6 is found to inhibit de novo lipogenesis (DNL) and promote fatty acid oxidation, thus mitigating hepatic lipid accumulation and pathological symptoms in MASLD mice. Further omics analysis and experiments reveal that B6 enhances the phosphorylation of AMPKα1 at Thr172 through the inhibition of HDAC11, consequently modulating DNL and fatty acid oxidation in the liver. In summary, this study identifies HDAC11 as a potential therapeutic target in MASLD and reports the discovery of a highly selective HDAC11 inhibitor with favorable drug‐like properties for the treatment of MASLD.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver Disease Diagnosis and Treatment · MicroRNA in disease regulation · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology the First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei 230001 China

Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes Hefei University of Technology Hefei 230031 China

Key Laboratory of Marine Drugs Chinese Ministry of Education School of Medicine and Pharmacy Ocean University of China 5 Yushan Road Qingdao 266003 China

Department of Drug Discovery and Biomedical Sciences College of Pharmacy Medical University of South Carolina Charleston SC 29425 USA

Marine Biomedical Research Institute of Qingdao Qingdao Shandong 266071 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (64)

Show source-provided references
1. 10.1038/s41591-018-0104-910.1038/s41591-018-0104-9 ↗
2. 10.1016/j.jhep.2014.12.01210.1016/j.jhep.2014.12.012 ↗
3. 10.1038/nrgastro.2017.10910.1038/nrgastro.2017.109 ↗
4. 10.1016/j.molmet.2021.10127410.1016/j.molmet.2021.101274 ↗
5. 10.1016/j.cmet.2018.10.01210.1016/j.cmet.2018.10.012 ↗
6. 10.1042/CS2022057210.1042/CS20220572 ↗
7. 10.1111/brv.1217810.1111/brv.12178 ↗
8. 10.3389/fnut.2024.128010010.3389/fnut.2024.1280100 ↗
9. 10.1371/journal.pone.003181210.1371/journal.pone.0031812 ↗
10. 10.1152/ajpendo.00396.201610.1152/ajpendo.00396.2016 ↗
11. 10.1111/j.1467-789X.2009.00642.x10.1111/j.1467-789X.2009.00642.x ↗
12. 10.1152/ajpregu.00153.201910.1152/ajpregu.00153.2019 ↗
13. 10.1038/s41587-023-01680-410.1038/s41587-023-01680-4 ↗
14. 10.1101/cshperspect.a01871310.1101/cshperspect.a018713 ↗
15. 10.1021/acschembio.7b0094210.1021/acschembio.7b00942 ↗
16. 10.1016/j.chembiol.2018.04.00710.1016/j.chembiol.2018.04.007 ↗
17. 10.1073/pnas.181536511610.1073/pnas.1815365116 ↗
18. 10.1073/pnas.211967811910.1073/pnas.2119678119 ↗
19. 10.1172/jci.insight.12015910.1172/jci.insight.120159 ↗
20. 10.1172/JCI16819210.1172/JCI168192 ↗
21. 10.1016/j.ebiom.2018.06.02510.1016/j.ebiom.2018.06.025 ↗
22. 10.1021/acs.jmedchem.3c0149110.1021/acs.jmedchem.3c01491 ↗
23. 10.1021/acschembio.2c0084010.1021/acschembio.2c00840 ↗
24. 10.1021/acs.jmedchem.6b0138510.1021/acs.jmedchem.6b01385 ↗
25. 10.1021/acschembio.9b0029210.1021/acschembio.9b00292 ↗
26. 10.1016/j.jsb.2013.02.01210.1016/j.jsb.2013.02.012 ↗
27. 10.1016/S1262-3636(07)70061-710.1016/S1262-3636(07)70061-7 ↗
28. Kohjima M. · Int. J. Mol. Med. · 2007 · 20 · 351
29. 10.3945/ajcn.114.09226210.3945/ajcn.114.092262 ↗
30. 10.1002/hep.3232410.1002/hep.32324 ↗
31. 10.1196/annals.1320.00210.1196/annals.1320.002 ↗
32. 10.1002/hep.2392710.1002/hep.23927 ↗
33. 10.1016/j.jhep.2014.10.03910.1016/j.jhep.2014.10.039 ↗
34. 10.1093/ije/dyt19210.1093/ije/dyt192 ↗
35. 10.1016/j.molcel.2022.09.01810.1016/j.molcel.2022.09.018 ↗
36. 10.1002/j.2040-4603.2018.tb00008.x10.1002/j.2040-4603.2018.tb00008.x ↗
37. 10.1053/j.gastro.2020.03.01010.1053/j.gastro.2020.03.010 ↗
38. 10.1152/physrev.00011.200810.1152/physrev.00011.2008 ↗
39. 10.1038/emm.2016.1610.1038/emm.2016.16 ↗
40. 10.1158/0008-5472.CAN-20-304410.1158/0008-5472.CAN-20-3044 ↗
41. 10.1111/febs.1545610.1111/febs.15456 ↗
42. 10.1042/bj346065910.1042/bj3460659 ↗
43. 10.3390/ijms1908241210.3390/ijms19082412 ↗
44. 10.1136/gutjnl-2019-31881310.1136/gutjnl-2019-318813 ↗
45. 10.1016/j.cld.2017.08.00310.1016/j.cld.2017.08.003 ↗
46. 10.1038/s41575-019-0210-210.1038/s41575-019-0210-2 ↗
47. 10.3390/biom1206082410.3390/biom12060824 ↗
48. 10.1038/s42255-022-00627-410.1038/s42255-022-00627-4 ↗
49. 10.1126/scitranslmed.aaz284110.1126/scitranslmed.aaz2841 ↗
50. 10.1111/liv.1502410.1111/liv.15024 ↗
51. 10.1016/j.tplants.2015.07.00510.1016/j.tplants.2015.07.005 ↗
52. 10.1016/j.bbagrm.2017.12.00210.1016/j.bbagrm.2017.12.002 ↗
53. 10.1161/ATVBAHA.117.30899210.1161/ATVBAHA.117.308992 ↗
54. 10.1111/j.1440-1681.2009.05279.x10.1111/j.1440-1681.2009.05279.x ↗
55. 10.1038/s41598-017-11630-110.1038/s41598-017-11630-1 ↗
56. 10.3389/fphys.2022.97029210.3389/fphys.2022.970292 ↗
57. 10.1016/j.ejmech.2024.11663410.1016/j.ejmech.2024.116634 ↗
58. 10.1080/15384101.2019.171131510.1080/15384101.2019.1711315 ↗
59. 10.1016/j.bmcl.2018.05.02110.1016/j.bmcl.2018.05.021 ↗
60. 10.1021/acs.jmedchem.1c0147210.1021/acs.jmedchem.1c01472 ↗
61. 10.1016/j.ejmech.2018.06.04110.1016/j.ejmech.2018.06.041 ↗
62. 10.1016/j.cell.2020.01.02510.1016/j.cell.2020.01.025 ↗
63. 10.1161/ATVBAHA.117.30963010.1161/ATVBAHA.117.309630 ↗
64. 10.1074/jbc.M112.35018110.1074/jbc.M112.350181 ↗